Key result
Endurance training in patients with chronic heart failure safely increased exercise time (P<0.0001) and anaerobic threshold (P<0.05) compared to optimal pharmacological treatment alone.
Why the study?
Does endurance training improve exercise capacity and quality of life safely in patients with chronic heart failure class II and III?
Population
80 patients with chronic heart failure class II and III, mean age 56.6+/-8.3 years, mean left ventricular…
Comparison
Endurance training vs Control group with continuation of optimal…
Design
RCT, randomized
Authors
Loading...
Endurance training may be added to optimal therapy for NYHA II-III HF; extends RCT evidence for exercise as safe adjunct improving capacity.
RCT (n=80)
Randomized
Does endurance training improve exercise capacity and quality of life safely in patients with chronic heart failure class II and III?
p-value: p=<0.0001
Endurance training in patients with chronic heart failure class II and III is safe and significantly improves exercise time, anaerobic threshold, and quality of life.
Robert P. Wielenga (1999) conducted an RCT in chronic heart failure (n=80). endurance training vs. continuation of optimal pharmacological treatment was evaluated on exercise time (p=<0.0001). Endurance training in patients with chronic heart failure safely increased exercise time (P<0.0001) and anaerobic threshold (P<0.05) compared to optimal pharmacological treatment alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: